Karydas Irini SurgeonDirector, Breast Center HYGEIA Hospital
Education & Academic Qualifications
- Graduate University of Athens Medical School
- Specialty: General Surgeon
- Postgraduate surgical training: senior registrar Guy’s Hospital Breast Unit (Professor John Hayward)
Wide local excision with radical axillary lymph node clearance in breast cancer. National and Kapodistrian University of Athens.
Fellowship in Societies, Membership in Journal Editorial Committees
ASCO (American Society of Clinical Oncology).
Hellenic Society of Breast Surgery and Breast International Group (BIG).
Hellenic Society of Surgery.
Athens Medical Society.
Hellenic Society of Breast Cancer research.
Contact person EORTC Breast Cooperative Group.
Hellenic Society of Psychosocial Oncology.
Hellenic Society of Preventive Medicine.
Hellenic Society of Senology.
Hellenic Society of Oncology
International Society against Breast Cancer.
International Association for Breast research.
International Society of Senology.
Editorial Board in Hellenic Society of Senology.
Director of Breast Center “HYGEIA” Hospital since 2003.
Breast Clinic “AGIOS SAVVAS” Hospital.
Guy’s Hospital Breast Unit.
Clinical & Research Interest
Breast surgery performed more than 20.000 breast operations and examined more than 300.000 women with breast disease (case load)
Study of new drug development in breast cancer.
EORTC Breast Cooperative Group Clinical studies (participation).
Clinical research regarding the value of breast concerning surgery.
Participation in immunology and transmission electromicroscopic research protocols “AGIOS SAVVAS” Hospital.
Participation in immunohistochemical and histopathologic research laboratory protocols “AGIOS SAVVAS” Hospital, “HYGEIA” Hospital.
Honors & Awards
2011 honorary award from the women’s organisation “DEMOKRATIKOS SYNAGERMOS (DISY)-Cyprus for social contribution.
First prizes on research papers at conferences.
Distinguished award for long standing clinical contribution “AGIOS SAVVAS” Hospital.
Co-editor in Current mastology2007.
Publication: Senology 1992 Excerpta Medica.
Fine needle aspiration cytology in primary breast angiosarcoma: a case report. Acta Cytol.2010 Sep-Oct;54 (5 Suppl): 764-70.
Cell-free DNA and RNA in plasma as a new molecular marker for prostate and breast cancer. Ann NY Acad Sci.2006 Sep;1075:235-4.3
Evidence for in vivo synergism between docetaxel and gemcitabine in patients with metastatic breast cancer. Ann Oncol.2004 Jan;15(1):95-9.
Treatment of operable breast cancer in the elderly: a randomized clinical trial EORTC 10850 comparing modified radical mastectomy with tumorectomy plus tamoxifen. Eur J Cancer. 2003 Feb;39(3):300-8.
Tamoxifen associated uterine pathology in breast cancer patients with abnormal bleeding. Anticancer Res.1998 Jan-Feb;18(1B):625-9.
Monocyte disorders associated with T cell defects in patients with solid tumors. Anticancer Res. 1992 Mar-Apr;12(2):489-94.
Adjuvant androgen treatment of operable breast cancer — a 20 year analysis. Eur J Surg Oncol. 1987 Apr;13(2):113-7.
Comparison of HER2 detection methods between central and regional laboratories in Greece. Clin Breast Cancer.2007 Oct;7(10):784-90.
Inherited cancer predisposition syndromes in Greece. Anticancer Res.2008 Mar-Apr; 28(2B):1341-7. Review.
Tamoxifen associated uterine pathology in breast cancer patients with abnormal bleeding. Anticancer Res. 1998 Jan-Feb;18(1B):625-9.